Search
Products
Community
Markets
Brokers
More
IN
Get started
Markets
/
South Korea
/
ETF market
/
483030
/
Analysis
KIWOOM US BLOCKBUSTER BIOTECH DRUGS PLUS
483030
Korea Stock Exchange
483030
Korea Stock Exchange
483030
Korea Stock Exchange
483030
Korea Stock Exchange
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
Discussions
Technicals
Seasonals
Key stats
Assets under management (AUM)
11.73 B
KRW
Fund flows (1Y)
3.97 B
KRW
Dividend yield (indicated)
0.38%
Discount/Premium to NAV
−0.6%
Shares outstanding
1.10 M
Expense ratio
0.49%
About KIWOOM US BLOCKBUSTER BIOTECH DRUGS PLUS
Issuer
KIWOOM SECURITIES
Brand
Kiwoom
Home page
kosef.co.kr
Inception date
May 28, 2024
Index tracked
Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net
Replication method
Physical
Management style
Passive
Primary advisor
Kiwoom Asset Management Co., Ltd.
ISIN
KR7483030003
Classification
Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharma, biotech & life sciences
Strategy
Vanilla
Geography
U.S.
Weighting scheme
Market cap
Selection criteria
Market cap
Returns
1 month
3 months
Year to date
1 year
3 years
5 years
Price performance
—
—
—
—
—
—
NAV total return
—
—
—
—
—
—
What's in the fund
As of March 6, 2025
Exposure type
Stocks
Bonds, Cash & Other
Health Technology
Stocks
95.55%
Health Technology
95.55%
Bonds, Cash & Other
4.45%
Cash
4.45%
Stock breakdown by region
62%
34%
2%
North America
62.52%
Europe
35.00%
Asia
2.49%
Latin America
0.00%
Africa
0.00%
Middle East
0.00%
Oceania
0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows